top of page

News

Apr 20

Renowned Physician and Longevity Expert Dr. Robert Lufkin Highlights MitoSense’s MOT™ Technology

Mar 5

MitoSense Congratulates Greenwood Genetic Center on $1.1 Million in Federal Alzheimer’s Funding and New Genetic Study Demonstrating Mitochondrial Restoration

Feb 6

MitoSense Sponsors Countdown For A Cure and Celebrates CFAC’s Annual Event

Jul 30, 2025

MitoSense to Attend MHSRS, August 4 -7, 2025

Jun 27, 2025

MitoSense's Collaboration with the VA and WRAIR Highlighted in House Hearing with HHS Secretary RFK, Jr.

Apr 30, 2025

MitoSense’s MOT™ Technology Featured In Newsmax Article Highlighting Secretary Kennedy’s Vision To Tackle Mitochondria Dysfunction To Fight Chronic Disease

MitoSense’s MOT™ technology was featured in a recent Newsmax article. The article highlights how U.S. Department of Health and Human...

Feb 3, 2025

MitoSense Secures Japanese Patent for Groundbreaking Mitochondria-Based Therapy for Neurodegenerative Diseases

February 4, 2025 – Plymouth, MA – MitoSense Inc., a pioneering biotechnology company specializing in mitochondria-based therapeutics, is...

Dec 2, 2024

MitoSense, Inc. Secures U.S. Patent for Innovative Treatment of Neurodegenerative Diseases

Plymouth, MA, Dec 2, 2024 – MitoSense, Inc., a pioneering research and development company focused on treatments for neurodegenerative...

bottom of page